TickerFacts.

Icon PLC (ICLR): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$825.84M
Year ended 2025-12-31
$1.52B2008-12-31: $127.23M2009-12-31: $140.11M2010-12-31: $125.97M2011-12-31: $68.12M2012-12-31: $110.84M2013-12-31: $167.68M2014-12-31: $254.89M2015-12-31: $339.21M2016-12-31: $371.27M2017-12-31: $399.63M2018-12-31: $439.27M2019-12-31: $494.96M2020-12-31: $457.63M2021-12-31: $693.52M2022-12-31: $1.36B2023-12-31: $1.49B2024-12-31: $1.52B2025-12-31: $825.84M$825.84M
2008-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$825.84M-45.7%2026-05-27, From 2025-01-01
2024-12-31$1.52B+2.0%2026-05-27, From 2024-01-01
2023-12-31$1.49Bn/c2026-05-27, From 2023-01-01
2022-12-31$1.36B+96.8%2025-02-21, From 2022-01-01
2021-12-31$693.52M+51.5%2024-02-23, From 2021-01-01
2020-12-31$457.63M-7.5%2023-02-24, From 2020-01-01
2019-12-31$494.96M+12.7%2022-03-01, From 2019-01-01
2018-12-31$439.27M+9.9%2021-02-24, From 2018-01-01
2017-12-31$399.63M+7.6%2020-02-27, From 2017-01-01
2016-12-31$371.27M+9.5%2019-03-01, From 2016-01-01
2015-12-31$339.21M+33.1%2018-02-28, From 2015-01-01
2014-12-31$254.89M+52.0%2017-02-28, From 2014-01-01
2013-12-31$167.68M+51.3%2016-03-23, From 2013-01-01
2012-12-31$110.84M+62.7%2015-03-12, From 2012-01-01
2011-12-31$68.12M-45.9%2014-03-12, From 2011-01-01
2010-12-31$125.97M-10.1%2013-03-06, From 2010-01-01
2009-12-31$140.11M+10.1%2012-03-02, From 2009-01-01
2008-12-31$127.23Mn/a2011-03-22, From 2008-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Icon PLC (ICLR)2025-12-31$825.84M-45.7%
Incyte Corp (INCY)2025-12-31$1.61B+967.7%
Iqvia Holdings Inc. (IQV)2025-12-31$3.33B+0.3%
Charles River Laboratories International, Inc. (CRL)2025-12-27$428.47M-27.3%
NRC Health (NRC)2025-12-31$30.21M-26.7%
MaxCyte, Inc. (MXCT)2025-12-31-$47.56Mn/m
OmniAb, Inc. (OABI)2025-12-31-$47.22Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$9.73Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$10.07Mn/m

Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗